Last reviewed · How we verify

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE

University College Hospital, Ibadan · Phase 1 active Small molecule Quality 0/100

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE is a Small molecule drug developed by University College Hospital, Ibadan. It is currently in Phase 1 development. Also known as: PLEURODESE.

At a glance

Generic nameCHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE
Also known asPLEURODESE
SponsorUniversity College Hospital, Ibadan
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE

What is CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE?

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE is a Small molecule drug developed by University College Hospital, Ibadan.

Who makes CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE?

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE is developed by University College Hospital, Ibadan (see full University College Hospital, Ibadan pipeline at /company/university-college-hospital-ibadan).

Is CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE also known as anything else?

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE is also known as PLEURODESE.

What development phase is CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE in?

CHEMICAL PLEURODESIS WITH POVIDONE-IODINE ALONE is in Phase 1.

Related